Outcomes for Medicare debridement intervals receiving dehydrated human amnion/chorion membrane
J Wound Care
.
2022 Oct 2;31(10):886.
doi: 10.12968/jowc.2022.31.10.886.
Authors
William H Tettelbach
1
2
3
4
5
6
7
,
Shawn M Cazzell
8
,
Brandon Hubbs
1
,
Julie L DeJong
1
,
R Allyn Forsyth
1
9
,
Alexander M Reyzelman
10
11
Affiliations
1
MIMEDX Group, Inc., GA, US.
2
College of Podiatric Medicine, Western University of Health Sciences.
3
Duke University School of Medicine, Department of Anesthesiology, NC, US.
4
American Professional Wound Care Association, LA, US.
5
Association for the Advancement of Wound Care, PA, US.
6
Western Peaks Specialty Hospital, UT, US.
7
Encompass Health & Rehabilitation Hospital of Utah, US.
8
Limb Preservation Platform Inc, Fresno, CA, US.
9
Department of Biology, San Diego State University, San Diego, CA, US.
10
Department of Medicine California School of Podiatric Medicine at Samuel Merritt University, CA, US.
11
Co-Director, UCSF Center for Limb Preservation and Diabetic Foot Center for Clinical Research, San Francisco, CA, US.
PMID:
36240797
DOI:
10.12968/jowc.2022.31.10.886
No abstract available
Publication types
Letter
Comment
MeSH terms
Aged
Allografts
Amnion*
Chorion
Debridement
Humans
Medicare*
United States